Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Tissue specific expression of retinoblastoma protein

A technology for expressing vectors and fusion polypeptides, applied in the direction of retinoblastoma protein, mammalian protein, peptide/protein components, etc., which can solve the problems of cell growth stagnation and unclear exact pathway of arrest

Inactive Publication Date: 2007-09-19
CANJI
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

RB arrests cell growth by blocking the exit from G phase into S phase (e.g., Dowdy et al. Cell 73:499-511(1993)), but the exact pathway of its arrest is still unclear

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tissue specific expression of retinoblastoma protein
  • Tissue specific expression of retinoblastoma protein
  • Tissue specific expression of retinoblastoma protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment I

[0081] E2F-RB fusion

[0082] A. Introduction

[0083] In this example, expression plasmids encoding different segments of E2F fused to RB56 polypeptides were constructed. RB56 is a subfragment of full-length RB that contains the "pocket" domain necessary for growth inhibition (Hiebert et al. MCB 13:3384-3391 (1993); Qin et al. Genes and Rev. .6: 953-964 (1992)). E2F194 comprises E2F amino acids 95-194. This fragment contains only the DNA-binding domain of E2F. E2F286 contains a DNA binding domain and a DP-1 heterodimerization domain. Both E2F fragments lack the N-terminal cyclin A-kinase-binding domain, which appears to downregulate the DNA-binding activity of E2F (Krek et al. Cell 83:1149-1158 (1995); Krek et al., Cell 78:161-172 (1994)).

[0084] B. Construction of the vector

[0085] Plasmid pCTM contains a CMV promoter, a triple adenoviral leader flanked by T7 and SP6 promoters, a multiple cloning site, and downstream of the multipl...

Embodiment II

[0108] Tissue-specific expression of E2F-RB fusions

[0109] A. Construction of recombinant adenovirus

[0110] In this experiment, recombinant adenoviruses containing the RB polypeptide under the control of a CMV promoter or the smooth muscle alpha-actin promoter were generated.

[0111]Isolation of the smooth muscle α-actin promoter (bases -670 to +5) by PCR from a genomic library, Reddy et al., "Construction of the human smooth muscle α-actin gene" J. Biol. Chems .265: 1683-1687 (1990), Nakano et al., "Transcriptional regulatory elements and the first intron 5' upstream of the human smooth muscle (aortic type) α-actin-encoding gene" Gene 99:285-289 (1991)), and added 5' Xho I and Avr II and 3' Xha I, Cla I and Hind III restriction enzyme sites for cloning purposes. The fragment was subcloned into a plasmid as an Xho I, Hind III fragment and sequenced to confirm its base composition. A fusion construct 286-56 was subcloned as an Xha I, Cla I fragment di...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Fusions of the transcription factor E2F and the retinoblastoma protein RB are provided, along with methods of treatment of hyperproliferative diseases.

Description

Background of the invention [0001] Both the retinoblastoma gene (RB) and the transcription factor E2F have key roles in cell growth control (see Adams, P. and Kaelin, W. Seminars in Cancer Biology 6:99-108 (1995) for a review). The RB locus is frequently inactivated in various human tumor cells. The wild-type RB gene (as in Bookstein et al., Science 247:712-715 (1990)) or wild-type RB protein (pRB) (such as Antelman et al., Oncogene 10:697-704 (1995)) reintroduction of RB-negative / RB mutant cells can inhibit the growth of these cells in culture as well as their tumorigenic capacity in vivo. [0002] The role of E2F is to activate the transcription of S phase genes, while RB represses its activity. RB arrests cell growth by blocking the exit from G phase into S phase (e.g., Dowdy et al. Cell 73:499-511 (1993)), but the exact pathway of its arrest is still unclear. [0003] Although E2F forms a complex with RB, complex formation is more efficient if an E2F-associated ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/62C12N15/09C07K19/00C07H21/04C07K5/00A61K38/00A61K35/12A61P35/00A61K31/7088A61K48/00A61P5/00A61P13/08A61P17/06A61P27/02A61P43/00C07K14/47C07K14/82
CPCA61K48/00C12N2799/022C07K2319/00C07K14/4736A61P13/08A61P17/06A61P27/02A61P35/00A61P43/00A61P5/00C07K19/00
Inventor D·安特尔曼R·J·格雷戈里K·N·维尔斯
Owner CANJI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com